Skip to main content
Veterinary Medicines

Duphamox Long Acting, 150mg/ml, solution injectable pour bovins, ovins et porcins

Authorised
  • Amoxicillin trihydrate

Product identification

Medicine name:
Duphamox Long Acting, 150mg/ml, solution injectable pour bovins, ovins et porcins
Active substance:
  • Amoxicillin trihydrate
Target species:
  • Sheep
  • Cattle
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    150.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Sheep
      • Meat and offal
        21
        day
      • Milk
        no withdrawal period
    • Cattle
      • Milk
        84
        hour
      • Meat and offal
        23
        day
    • Pig
      • Meat and offal
        21
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CA04
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Available in:
  • Luxembourg
Package description:
  • Duphamox LA 100 ml Vial Suspension for injection
  • Duphamox LA 250 ml Vial Suspension for injection
  • Duphamox LA 12 100 ml Vial Suspension for injection
  • Duphamox LA 12 250 ml Vial Suspension for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Manufacturing Limited
  • Norbrook Laboratories Limited
Responsible authority:
  • Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
  • V 087/91/05/0320
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 2/02/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."